CA - Aptose Biosciences GAAP EPS of -$0.11 beats by $0.01 November, 01 2022 04:40 PM CA Inc. Aptose Biosciences ( NASDAQ: APTO ): Q3 GAAP EPS of -$0.11 beats by $0.01 . Total cash and cash equivalents and investments as of September 30, 2022 were $55.4 million. For further details see: Aptose Biosciences GAAP EPS of -$0.11 beats by $0.01